Menu
Back to Journals » Clinical Ophthalmology » Volume 4
Evaluation of ultraviolet light toxicity on cultured retinal pigment epithelial and retinal ganglion cells
Authors Balaiya S, Murthy RK, Brar VS, Chalam K
Published 7 January 2010 Volume 2010:4 Pages 33—39
DOI https://doi.org/10.2147/OPTH.S7979
Review by Single anonymous peer review
Peer reviewer comments 2
Sankarathi Balaiya, Ravi K Murthy, Vikram S Brar, Kakarla V Chalam
Department of Ophthalmology, University of Florida College of Medicine, Jacksonville, FL, USA
Purpose: Our study is aimed at evaluating the role of UVB light in inducing cytotoxicity in an in vitro model.
Methods: RGC-5 and ARPE-19 cells were exposed to different time periods of UVB light: 0, 15, 30, and 45 min. They were subsequently examined for changes in cell morphology, cell viability (neutral red uptake assay), generation of reactive oxygen species (ROS), expression of bax, bcl-2 and cytochome C by reverse transcriptase polymerase chain reaction and western blot, respectively.
Results: Dose-dependent reduction in cell viability to UVB light was demonstrated with parallel increase in ROS. Increased duration of exposure (>15 minutes), was associated with increased expression of bax and cytochrome C, and absence of bcl-2 expression.
Conclusion: UVB light exposure results in cell cytotoxicity. The concomitant generation of ROS and expression of apoptotic markers suggests the role of oxidative stress in UVB-mediated apoptosis in an in vitro model of retinal ganglion and pigment epithelial cells.
Keywords: ultraviolet light, retinal pigment epithelium, retinal ganglion cell, reactive oxygen species, cytochrome C
© 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.